Niagen Bioscience, Inc. — Director's Dealing 2022

Jun 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2022-06-16

Reporting Person: Chau Hoi Shuen Solina Holly (10% Owner)
Reporting Person: Pioneer Step Holdings Ltd (10% Owner)
Reporting Person: Dvorak International Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-16	Common Stock	P	60037	$1.6636	Acquired	6925641	Indirect

Footnotes

F1: Skyinvest Associates Limited ("Skyinvest Associates") acquired 60,037 shares of the Issuer's common stock in open market purchases on June 16, 2022.

F2: Of the total shares beneficially owned following the reported transaction (i) 5,957,783 shares of the Issuer's common stock are held directly by Pioneer Step Holdings Limited ("Pioneer Step"), (ii) 420,000 shares of the Issuer's common stock are held directly by Dvorak International Limited ("Dvorak International"), and (iii) 547,858 shares of the Issuer's common stock are held directly by Skyinvest Associates. Chau Hoi Shuen Solina Holly ("Solina Chau") is the sole shareholder of each of Pioneer Step and Dvorak International, and Skyinvest Associates is wholly-owned by Solina Chau through intermediate entities that are directly or indirectly wholly-owned by Solina Chau.

F3: (continued from Footnote 2) As such, Solina Chau may be deemed to beneficially own the shares of the Issuer's common stock directly held by Pioneer Step, Dvorak International and Skyinvest Associates. Solina Chau disclaims Section 16 beneficial ownership of the securities held by each of Pioneer Step, Dvorak International and Skyinvest Associates, except to the extent of her pecuniary interest therein, if any.